19th Nov 2014 13:16
19 November 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the 'Company")
Result of Annual General Meeting
Allergy Therapeutics plc announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer | |
Ian Postlethwaite, Finance Director | |
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel | |
Clare Terlouw | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway | |
Victoria Foster Mitchell |
Note to editors
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.Ithas a growing business achieving revenue in thelast financial year of £42 million mainly in Europe through its own sales and
marketing infrastructure and further afield through distributors.The Company is expanding its infrastructure into the Emerging markets.
Related Shares:
Allergy Thera.